| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medical Biophysics and Immunology, Ontario Cancer Institute/Amgen Institute, University of Toronto, 510 University Avenue, Toronto, Ontario M5G 2M9 [A. H. R., T. C. Y. C., T. W. M.]; Departments of Pathology and Laboratory Medicine and Surgery, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, 600 University Avenue, Toronto, Ontario M5G 1X5 [M. R., J. C. C., K. H., S. G., B. B.]; Department of Anatomy and Cell Biology, University of Toronto, Medical Sciences Building, Toronto, Ontario M5S 1A8 [M. B., H. C.], Canada; and Department of Oncology and Cancer Research Institute, Fujian Union Hospital, Fujian Medical University, Fuzhou 350001, China [J. C. C.]
Hereditary nonpolyposis colorectal cancer is associated with defects in DNA mismatch repair. Here, we characterize tumor susceptibility of the recently described Msh2-deficient mouse model. Within the first year of observation, all homozygous mice succumbed to disease, with lymphomas observed in at least 80% of the cases. The majority (70%) of animals 6 months or older developed intestinal neoplasms associated with APC inactivation. Microsatellite instability was more common in carcinomas than in adenomas, but uncommon in normal tissues. Some animals (7%) developed a variety of skin neoplasms analogous to the Muir-Torre syndrome. Msh2-/- mice implicate a direct role for mismatch repair in several neoplasms with striking phenotypic similarities to humans.
1 This work was supported in part by grants from the National Cancer Institute of Canada (to M. R., B. B., S. G., T. W. M.) and the Medical Research Council of Canada (to M. B., H. C., T. W. M.). A. H. R. was supported by a stipend from the German Academic Exchange Service (DAAD-Doktorandenstipendium aus Mitteln des zweiten Hochschulsonderprogramms).
2 To whom requests for reprints should be addressed.
Received 4/15/96. Accepted 6/10/96.
This article has been cited by other articles:
![]() |
H. Feitsma, R. V. Kuiper, J. Korving, I. J. Nijman, and E. Cuppen Zebrafish with Mutations in Mismatch Repair Genes Develop Neurofibromas and Other Tumors Cancer Res., July 1, 2008; 68(13): 5059 - 5066. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. van Boxtel, P. W. Toonen, H. S. van Roekel, M. Verheul, B. M. G. Smits, J. Korving, A. de Bruin, and E. Cuppen Lack of DNA mismatch repair protein MSH6 in the rat results in hereditary non-polyposis colorectal cancer-like tumorigenesis Carcinogenesis, June 1, 2008; 29(6): 1290 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Rustgi The genetics of hereditary colon cancer Genes & Dev., October 15, 2007; 21(20): 2525 - 2538. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Gammie, N. Erdeniz, J. Beaver, B. Devlin, A. Nanji, and M. D. Rose Functional Characterization of Pathogenic Human MSH2 Missense Mutations in Saccharomyces cerevisiae Genetics, October 1, 2007; 177(2): 707 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Neri, A. Gardini, A. Facchini, F. Olivieri, C. Franceschi, G. Ravaglia, and E. Mariani Mismatch Repair System and Aging: Microsatellite Instability in Peripheral Blood Cells From Differently Aged Participants J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2005; 60(3): 285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Young, K. J. Thulien, M. R. Campbell, V. A. Tron, and S. E. Andrew DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study Carcinogenesis, October 1, 2004; 25(10): 1821 - 1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Lin, Y. Wang, S. J. Scherer, A. B. Clark, K. Yang, E. Avdievich, B. Jin, U. Werling, T. Parris, N. Kurihara, et al. An Msh2 Point Mutation Uncouples DNA Mismatch Repair and Apoptosis Cancer Res., January 15, 2004; 64(2): 517 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Krynetskaia, T. L. Brenner, E. Y. Krynetski, W. Du, J. C. Panetta, P. Ching-Hon, and W. E. Evans Msh2 Deficiency Attenuates But Does Not Abolish Thiopurine Hematopoietic Toxicity in Msh2-/- Mice Mol. Pharmacol., August 1, 2003; 64(2): 456 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Claij, A. van der Wal, M. Dekker, L. Jansen, and H. te Riele DNA Mismatch Repair Deficiency Stimulates N-Ethyl-N-nitrosourea-induced Mutagenesis and Lymphomagenesis Cancer Res., May 1, 2003; 63(9): 2062 - 2066. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wei, A. B. Clark, E. Wong, M. F. Kane, D. J. Mazur, T. Parris, N. K. Kolas, R. Russell, H. Hou Jr., B. Kneitz, et al. Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility Genes & Dev., March 1, 2003; 17(5): 603 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Goldsby, L. E. Hays, X. Chen, E. A. Olmsted, W. B. Slayton, G. J. Spangrude, and B. D. Preston High incidence of epithelial cancers in mice deficient for DNA polymerase delta proofreading PNAS, November 26, 2002; 99(24): 15560 - 15565. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. J. Kohonen-Corish, J. J. Daniel, H. te Riele, G. D. Buffinton, and J. E. Dahlstrom Susceptibility of Msh2-deficient Mice to Inflammation-associated Colorectal Tumors Cancer Res., April 1, 2002; 62(7): 2092 - 2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Whiteside, R. McLeod, G. Graham, J. L. Steckley, K. Booth, M. J. Somerville, and S. E. Andrew A Homozygous Germ-Line Mutation in the Human MSH2 Gene Predisposes to Hematological Malignancy and Multiple Cafe-au-Lait Spots Cancer Res., January 1, 2002; 62(2): 359 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kuraguchi, K. Yang, E. Wong, E. Avdievich, K. Fan, R. D. Kolodner, M. Lipkin, A. M. C. Brown, R. Kucherlapati, and W. Edelmann The Distinct Spectra of Tumor-associated Apc Mutations in Mismatch Repair-deficient Apc1638N Mice Define the Roles of MSH3 and MSH6 in DNA Repair and Intestinal Tumorigenesis Cancer Res., November 1, 2001; 61(21): 7934 - 7942. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Colussi, S. Fiumicino, A. Giuliani, S. Rosini, P. Musiani, C. Macri, C. S. Potten, M. Crescenzi, and M. Bignami 1,2-Dimethylhydrazine-Induced Colon Carcinoma and Lymphoma in msh2-/- Mice J Natl Cancer Inst, October 17, 2001; 93(20): 1534 - 1540. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zanesi, V. Fidanza, L. Y. Fong, R. Mancini, T. Druck, M. Valtieri, T. Rudiger, P. A. McCue, C. M. Croce, and K. Huebner The tumor spectrum in FHIT-deficient mice PNAS, August 17, 2001; (2001) 191345898. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lal, C. Ash, K. Hay, M. Redston, E. Kwong, B. Hancock, T. Mak, S. Kargman, J. F. Evans, and S. Gallinger Suppression of Intestinal Polyps in Msh2-deficient and Non-Msh2-deficient Multiple Intestinal Neoplasia Mice by a Specific Cyclooxygenase-2 Inhibitor and by a Dual Cyclooxygenase-1/2 Inhibitor Cancer Res., August 1, 2001; 61(16): 6131 - 6136. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. S. Xu, L. Narayanan, B. Dunklee, R. M. Liskay, and P. M. Glazer Hypermutability to Ionizing Radiation in Mismatch Repair-deficient, Pms2 Knockout Mice Cancer Res., May 1, 2001; 61(9): 3775 - 3780. [Abstract] [Full Text] |
||||
![]() |
N. Watanabe, E. Okochi, Y. Hirayama, Y. Shimada, K. Yanagihara, M. C. Yoshida, S. Takahashi, M. Mochizuki, T. Sugimura, M. Nagao, et al. Single Nucleotide Instability without Microsatellite Instability in Rat Mammary Carcinomas Cancer Res., March 1, 2001; 61(6): 2632 - 2640. [Abstract] [Full Text] |
||||
![]() |
W. K. Hansen and M. R. Kelley Review of Mammalian DNA Repair and Translational Implications J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 1 - 9. [Abstract] [Full Text] |
||||
![]() |
S. E. Andrew, X. S. Xu, A. Baross-Francis, L. Narayanan, K. Milhausen, R.M. Liskay, F. R. Jirik, and P. M. Glazer Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts Carcinogenesis, July 1, 2000; 21(7): 1291 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Song, K.-J. Sohn, A. Medline, C. Ash, S. Gallinger, and Y.-I. Kim Chemopreventive Effects of Dietary Folate on Intestinal Polyps in Apc+/- Msh2-/- Mice Cancer Res., June 1, 2000; 60(12): 3191 - 3199. [Abstract] [Full Text] |
||||
![]() |
X. Qin, D. Shibata, and S. L. Gerson Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea Carcinogenesis, April 1, 2000; 21(4): 833 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Edelmann, A. Umar, K. Yang, J. Heyer, M. Kucherlapati, M. Lia, B. Kneitz, E. Avdievich, K. Fan, E. Wong, et al. The DNA Mismatch Repair Genes Msh3 and Msh6 Cooperate in Intestinal Tumor Suppression Cancer Res., February 1, 2000; 60(4): 803 - 807. [Abstract] [Full Text] |
||||
![]() |
A. Abuin, H. Zhang, and A. Bradley Genetic Analysis of Mouse Embryonic Stem Cells Bearing Msh3 and Msh2 Single and Compound Mutations Mol. Cell. Biol., January 1, 2000; 20(1): 149 - 157. [Abstract] [Full Text] |
||||
![]() |
C. Sevignani, A. Cranston, R. V. Iozzo, R. Fishel, and B. Calabretta Spontaneous and Mutagen-induced Transformation of Primary Cultures of Msh2-/- p53-/- Colonocytes Cancer Res., December 1, 1999; 59(23): 5882 - 5886. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Kolodner, J. D. Tytell, J. L. Schmeits, M. F. Kane, R. Das Gupta, J. Weger, S. Wahlberg, E. A. Fox, D. Peel, A. Ziogas, et al. Germ-line msh6 Mutations in Colorectal Cancer Families Cancer Res., October 1, 1999; 59(20): 5068 - 5074. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qin, H. Zhou, L. Liu, and S. L. Gerson Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis Carcinogenesis, September 1, 1999; 20(9): 1667 - 1673. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yao, A. B. Buermeyer, L. Narayanan, D. Tran, S. M. Baker, T. A. Prolla, P. M. Glazer, R. M. Liskay, and N. Arnheim Different mutator phenotypes in Mlh1- versus Pms2-deficient mice PNAS, June 8, 1999; 96(12): 6850 - 6855. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. de Vries, E. B. Baart, M. Dekker, A. Siezen, D. G. de Rooij, P. de Boer, and H. te Riele Mouse MutS-like protein Msh5 is required for proper chromosome synapsis in male and female meiosis Genes & Dev., March 1, 1999; 13(5): 523 - 531. [Abstract] [Full Text] |
||||
![]() |
K. A. Vora, K. M. Tumas-Brundage, V. M. Lentz, A. Cranston, R. Fishel, and T. Manser Severe Attenuation of the B Cell Immune Response in Msh2-deficient Mice J. Exp. Med., February 1, 1999; 189(3): 471 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baross-Francis, S. E. Andrew, J. E. Penney, and F. R. Jirik Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability PNAS, July 21, 1998; 95(15): 8739 - 8743. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Andrew, M. McKinnon, B. S. Cheng, A. Francis, J. Penney, A. H. Reitmair, T. W. Mak, and F. R. Jirik Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent PNAS, February 3, 1998; 95(3): 1126 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Y. Y. Fong, V. Fidanza, N. Zanesi, L. F. Lock, L. D. Siracusa, R. Mancini, Z. Siprashvili, M. Ottey, S. E. Martin, T. Druck, et al. Muir-Torre-like syndrome in Fhit-deficient mice PNAS, April 25, 2000; 97(9): 4742 - 4747. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zanesi, V. Fidanza, L. Y. Fong, R. Mancini, T. Druck, M. Valtieri, T. Rudiger, P. A. McCue, C. M. Croce, and K. Huebner The tumor spectrum in FHIT-deficient mice PNAS, August 28, 2001; 98(18): 10250 - 10255. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |